Search results
Andrew Tate, 'King of Toxic Masculinity,' faces 3 legal cases in 2 countries
Good Morning America via Yahoo News· 3 days agoIn Romania, where Tate has made his home for several years, he and his younger brother, Tristan, are...
Evolving With the Virus: Repeat COVID-19 Shots Neutralizing Beyond the Expected
SciTechDaily· 1 day agoThe response to an updated vaccine is influenced by previous vaccinations but also produces broadly...
Five Key Takeaways from the Most Important Book on the Teen Mental Health Crisis
The Oprah Magazine via Yahoo News· 17 hours agoSmartphones don’t have to mean your teenager is doomed, says author Jonathan Haidt, but their impact...
Low-FODMAP, Low-Carb Diets May Beat Medical Tx for IBS
Medscape· 3 days agoDietary interventions could be considered as an initial treatment for patients with IBS, although...
Cancer in Canada: Increasing Cases, Decreasing Diagnoses
Medscape· 3 days agoThe numbers of cancer cases and deaths are rising in Canada, even as overall rates of cancer...
American Council of Learned Societies Releases New Report on Career Pathways for Humanities PhDs
PRWeb· 4 days ago"We hope it can be useful to current PhD students who seek to understand the range of possible futures before them and to those who support every element of doctoral education—faculty ...
Exploring PAs' Hesitance to Use Mental Health Provider Plans
Medscape· 3 days agoDuring her training as a physician associate (PA), Stephanie Neary, MPA, MMS, PA-C, assistant...
Husson University Dean Dr. James Nash Selected to | Newswise
Newswise· 1 day agoBethesda, MD – Dr. James Nash, professor and dean of the College of Health and Pharmacy at Husson...
FDA Roundup: May 21, 2024
WTNH-TV New Haven· 2 days agoRegistration is required for both online and on-site attendance. On Monday, the FDA Oncology Center of Excellence (OCE) announced the formation of The OCE Equity ...
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO...
Morningstar· 11 hours agoOPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration of response (median ...